Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Axt L, Naumann A, Toennies J, Haen SP, Vogel W, Schneidawind D, Wirths S, Moehle R, Faul C, Kanz L, Axt S, Bethge WA.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0544-y. [Epub ahead of print]

PMID:
31089279
2.

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma.

Löffler MW, Mohr C, Bichmann L, Freudenmann LK, Walzer M, Schroeder CM, Trautwein N, Hilke FJ, Zinser RS, Mühlenbruch L, Kowalewski DJ, Schuster H, Sturm M, Matthes J, Riess O, Czemmel S, Nahnsen S, Königsrainer I, Thiel K, Nadalin S, Beckert S, Bösmüller H, Fend F, Velic A, Maček B, Haen SP, Buonaguro L, Kohlbacher O, Stevanović S, Königsrainer A; HEPAVAC Consortium, Rammensee HG.

Genome Med. 2019 Apr 30;11(1):28. doi: 10.1186/s13073-019-0636-8.

3.

Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.

Yurttas C, Hoffmann G, Tolios A, Haen SP, Schwab M, Königsrainer I, Königsrainer A, Beckert S, Löffler MW.

J Clin Med. 2018 Dec 19;7(12). pii: E567. doi: 10.3390/jcm7120567. Review.

4.

First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.

Löffler MW, Steinhilber J, Hilke FJ, Haen SP, Bösmüller H, Montes-Mojarro IA, Bonzheim I, Stäbler A, Faust U, Grasshoff U, Königsrainer I, Rammensee HG, Kanz L, Königsrainer A, Beckert S, Riess O, Schroeder C.

BMC Med Genet. 2018 Aug 15;19(1):144. doi: 10.1186/s12881-018-0651-4.

5.

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

Löffler MW, Kowalewski DJ, Backert L, Bernhardt J, Adam P, Schuster H, Dengler F, Backes D, Kopp HG, Beckert S, Wagner S, Königsrainer I, Kohlbacher O, Kanz L, Königsrainer A, Rammensee HG, Stevanović S, Haen SP.

Cancer Res. 2018 Aug 15;78(16):4627-4641. doi: 10.1158/0008-5472.CAN-17-1745. Epub 2018 May 22.

6.

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells.

Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, Hinterleitner C, Märklin M, Kopp HG, Salih HR.

Oncoimmunology. 2017 Nov 27;7(2):e1364827. doi: 10.1080/2162402X.2017.1364827. eCollection 2018.

7.

The immunopeptidomic landscape of ovarian carcinomas.

Schuster H, Peper JK, Bösmüller HC, Röhle K, Backert L, Bilich T, Ney B, Löffler MW, Kowalewski DJ, Trautwein N, Rabsteyn A, Engler T, Braun S, Haen SP, Walz JS, Schmid-Horch B, Brucker SY, Wallwiener D, Kohlbacher O, Fend F, Rammensee HG, Stevanović S, Staebler A, Wagner P.

Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951. doi: 10.1073/pnas.1707658114. Epub 2017 Nov 1.

8.

Vessels, T cells, and GVHD: time matters.

Haen SP.

Blood. 2017 Apr 6;129(14):1898-1899. doi: 10.1182/blood-2017-02-764696. No abstract available.

9.

Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.

Haen SP, Groh C, Schumm M, Backert L, Löffler MW, Federmann B, Faul C, Dörfel D, Vogel W, Handgretinger R, Kanz L, Bethge WA.

Ann Hematol. 2017 May;96(5):817-827. doi: 10.1007/s00277-017-2941-x. Epub 2017 Feb 28.

PMID:
28247058
10.

Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Haen SP, Eyb V, Mirza N, Naumann A, Peter A, Löffler MW, Faul C, Vogel W, Bethge WA, Rammensee HG, Kanz L, Heni M.

J Cancer Res Clin Oncol. 2017 May;143(5):759-771. doi: 10.1007/s00432-017-2348-z. Epub 2017 Feb 16.

PMID:
28210842
11.

Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols.

Löffler MW, Schuster H, Zeck A, Quilitz N, Weinreich J, Tolios A, Haen SP, Horvath P, Löb S, Rammensee HG, Königsrainer I, Königsrainer A, Beckert S.

Ann Surg Oncol. 2017 Jun;24(6):1650-1657. doi: 10.1245/s10434-017-5790-x. Epub 2017 Feb 3.

PMID:
28160138
12.

Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

Mirza N, Zierhut M, Korn A, Bornemann A, Vogel W, Schmid-Horch B, Bethge WA, Stevanović S, Salih HR, Kanz L, Rammensee HG, Haen SP.

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13827-13832. Epub 2016 Nov 10.

13.

An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia.

Koerner SP, André MC, Leibold JS, Kousis PC, Kübler A, Pal M, Haen SP, Bühring HJ, Grosse-Hovest L, Jung G, Salih HR.

Leukemia. 2017 Feb;31(2):459-469. doi: 10.1038/leu.2016.194. Epub 2016 Jul 20.

PMID:
27435001
14.

Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?

Haen SP, Pham M, Faul C, Dörfel D, Vogel W, Kanz L, Bethge WA.

Blood Cancer J. 2016 Jul 8;6(7):e443. doi: 10.1038/bcj.2016.54. No abstract available.

15.

[Hematologic chest pain].

Haen SP, Mannal R, Steeg M, Seizer P, Rockenstiehl M, Mackensen-Haen S, Horger M, Kanz L, Vogel W.

Dtsch Med Wochenschr. 2016 Apr;141(9):634. doi: 10.1055/s-0041-109909. Epub 2016 Apr 28. German.

PMID:
27123729
16.

Soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation.

Mirza N, Prokop L, Kowalewski D, Gouttefangeas C, Faul C, Bethge WA, Vogel W, Kanz L, Rammensee HG, Haen SP.

Transpl Immunol. 2016 May;36:25-31. doi: 10.1016/j.trim.2016.03.003. Epub 2016 Mar 25.

PMID:
27020764
17.

Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab.

Haen SP, Schmiedel BJ, Rothfelder K, Schmied BJ, Dang TM, Mirza N, Möhle R, Kanz L, Vogel W, Salih HR.

Oncotarget. 2016 Mar 15;7(11):13013-30. doi: 10.18632/oncotarget.7344.

18.

Choroidal metastases from thymic carcinoma during pregnancy: Case Report.

Haen SP, Stroebel P, Marx A, Suesskind D, Fend F, Reichmann U, Kopp HG, Kanz L, Mayer F.

BMC Cancer. 2015 Dec 16;15:972. doi: 10.1186/s12885-015-1968-4.

19.

Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.

Haen SP, Schumm M, Faul C, Kanz L, Bethge WA, Vogel W.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2241-51. doi: 10.1007/s00432-015-2027-x. Epub 2015 Aug 14.

PMID:
26272482
20.

The repertoire of human tumor-associated epitopes--identification and selection of antigens and their application in clinical trials.

Haen SP, Rammensee HG.

Curr Opin Immunol. 2013 Apr;25(2):277-83. doi: 10.1016/j.coi.2013.03.007. Epub 2013 Apr 23. Review.

PMID:
23619309
21.

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.

Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm S, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G.

Leukemia. 2012 Jun;26(6):1228-37. doi: 10.1038/leu.2011.372. Epub 2012 Jan 6.

PMID:
22289926
22.

More than just tumor destruction: immunomodulation by thermal ablation of cancer.

Haen SP, Pereira PL, Salih HR, Rammensee HG, Gouttefangeas C.

Clin Dev Immunol. 2011;2011:160250. doi: 10.1155/2011/160250. Epub 2011 Dec 29. Review.

23.

Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.

Haen SP, Gouttefangeas C, Schmidt D, Boss A, Clasen S, von Herbay A, Kosan B, Aebert H, Pereira PL, Rammensee HG.

Cell Stress Chaperones. 2011 Sep;16(5):495-504. doi: 10.1007/s12192-011-0261-y. Epub 2011 Mar 26.

24.

Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.

Widenmeyer M, Shebzukhov Y, Haen SP, Schmidt D, Clasen S, Boss A, Kuprash DV, Nedospasov SA, Stenzl A, Aebert H, Wernet D, Stevanović S, Pereira PL, Rammensee HG, Gouttefangeas C.

Int J Cancer. 2011 Jun 1;128(11):2653-62. doi: 10.1002/ijc.25601. Epub 2010 Oct 8.

25.

Particle size and activation threshold: a new dimension of danger signaling.

Rettig L, Haen SP, Bittermann AG, von Boehmer L, Curioni A, Krämer SD, Knuth A, Pascolo S.

Blood. 2010 Jun 3;115(22):4533-41. doi: 10.1182/blood-2009-11-247817. Epub 2010 Mar 19.

26.

Fundus autofluorescence in multifocal choroiditis and panuveitis.

Haen SP, Spaide RF.

Am J Ophthalmol. 2008 May;145(5):847-53. doi: 10.1016/j.ajo.2008.01.008. Epub 2008 Mar 10.

PMID:
18329623
27.

The white dot syndromes.

Matsumoto Y, Haen SP, Spaide RF.

Compr Ophthalmol Update. 2007 Jul-Aug;8(4):179-200; discussion 203-4. Review.

PMID:
17999832

Supplemental Content

Support Center